Skip to main content
Premium Trial:

Request an Annual Quote

Syapse, Seoul National University Hospital Renew Precision Oncology Partnership

NEW YORK – Syapse, a maker of software to support precision oncology care, said today that it has extended its partnership with Seoul National University Hospital through a new, multiyear agreement. Length of the deal and financial terms were not disclosed.

San Francisco-based Syapse and the hospital said that they will "work toward building South Korea's first real-world data sharing network" for precision oncology. The partners envision that the network will serve other Asian countries as well. 

"Together we will work to build a precision medicine data sharing network in the region that will provide the high-quality real-world data and insights required to support hospitals in delivering the most informed personalized care to every cancer patient," Syapse CEO Ken Tarkoff said in a statement.  

Seoul National University Hospital and Syapse formed their partnership in January 2018. The health system agreed to install the Syapse data-aggregation platform in its 28 cancer centers across South Korea. Syapse entered into a deal then with cloud IT vendor Megazone to help the company reach other potential customers in Korea, Japan, and Vietnam.

In the last year and a half, Syapse and Seoul National University Hospital have been focusing on integrating and curating clinical, molecular, and outcomes data to scale up the capability to deliver precision cancer care, the partners said. 

The technology company and the hospital system also announced today that they would co-host a precision oncology symposium Nov. 22-23 in Seoul. East Asian Syapse customers, collectively known as the Syapse Precision Medicine Council Asia, will be invited to discuss best practices in establishing precision medicine programs and leveraging existing data sharing initiatives, among other topics.


The Scan

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce.

Biotech Co-Founder Arrested

A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News.

Return of the Tasmanian Tiger

The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction.

Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More

In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.